Alex Rapoport

Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA.

VALKEE Oy develops and manufactures health devices. Its flagship product Valkee is a pocket-sized light therapy device that channels bright light via the ear canals into the brain that has beneficial effects on mood and wellbeing of people. The firm is carrying out additional tests and studies concerning the effects of bright light on cognitive and physical performance and jet lag. The company was founded by Juuso Samuel Nissilä and Antti Aunio in 2007 and is headquartered in Oulu, Finland.

Les Nouvelles Éditions Indépendantes SASU operates as a holding company, with interest in newspaper publishing. The company was founded on July 27, 2009 and is headquartered in Paris, France.

Rythm SAS develops a device which helps to monitor and analyze the sleep. Its product, Dreem, is a sleep solution that monitors, analyzes, and acts on brain to enhance sleep. The company was founded by Hugo Mercier and Quentin Soulet de Brugière in 2014 and is headquartered in Paris, France.

Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA.

Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country.

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Part of ResMed, Inc., ResMed Medizintechnik GmbH is a medical device manufacturer. The company is based in Gremsdorf, Germany. The German company was founded in 1993. The CEO is Anne Reiser.

Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation.

Mablink Bioscience is a biotechnology company based in Lyon, France that develops next-generation antibody-drug conjugates for the treatment of solid tumors. Mablink Bioscience's exclusive PSarlink™ platform is a unique stealth technology that "masks" the hydrophobicity of the cytotoxic drugs by adding a polysarcosine chain to the linker. The French company's pipeline is built on the topoisomerase-I inhibitor exatecan as a payload for current developments. Recently, the company announced the publication of a review article titled “Payload Diversification\: A Key Step in the Development of Antibody–Drug Conjugates” which reviews the history of the successes and failures in ADC payloads and takes a look at the new roads currently explored by the industry. The company was founded in 2018 by Warren Viricel and Jean-Guillaume Lafay, with Jean-Guillaume Lafay serving as CEO since then.

Rainmaker Labs Pte Ltd. develops software application for mobile phones. Its solutions include automotive, financial services, customer and retail, energy and utilities, engineering and healthcare and logistics. The company was founded by Neo Zhizhong, Alex Leong and Andrew Wong in March 2011 and is headquartered in Singapore.

Part of Qantas Airways Ltd., Valuair Ltd. is a budget airline based in Singapore, Singapore. The Singaporean company was founded by Natasha Foong. Valuair was acquired by Jetstar Asia Airways Pte Ltd. on July 25, 2005.

IncuVest Pte Ltd (IncuVest) is a venture capital firm founded in 2011 by Ronnie Wee, Natasha Foong and Kevin Lam. The firm is headquartered in Singapore.

NUS Enterprise provides an enterprise dimension to NUS teaching and research that involves the university?s students, staff, and alumni. It offers experiential entrepreneurial education, active industry partnerships, comprehensive entrepreneurship support, and catalytic entrepreneurship outreach. The company was founded in 2001 and is headquartered in Singapore.

Hollister, Inc. develops, manufactures and markets healthcare products and services. Its products include Ostomy, continence, wound, skin and critical care products. The company was founded by John Dickinson Schneider in 1921 and is headquartered in Libertyville, IL.

CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland.

Lumithera, Inc. manufactures medical devices. It offers treatment for age-related macular degeneration. The company was founded by Clark E. Tedford, Graham Merry, James Carroll, Luis DeTaboada and Robert Dotson in 2013 and is headquartered in Poulsbo, WA.

4see Ventures operates as a venture capital firm. It focuses in biotech, medtech and healthcare, technology, sustainable finance and new energy. The company was founded by Daniel Bertholet and is headquartered in Geneva, Switzerland.

Medingo Ltd. engages in developing a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or injections. Medingo's product is Solo MicroPump. The company was founded on November 2, 2005 and is headquartered in Tel Aviv, Israel.

Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel.

Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry.

Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel.

Tarsier Pharma Ltd. operates as a research and development company focusing on development of drug candidates in the field of ophthalmology. It develops a novel treatment for uveitis based on technology inspired by biomimetics. The company was founded by Daphne Haim-Langford in February 2016 and is headquartered in Zichron Yaacov, Israel.

Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel.